MONITORING, SURVEILLANCE AND NATIONAL PLANS
AMR CONTROL 2015 53
References
1.xiao YH, Giske CG, Wei ZQ, Shen P, Hedinni A, Li LJ. Epidemiology and characteristics
of antimicrobial resistance in China. Drug Resist Updat 2011; 14(4-5):236-250.
2.xiao YH, Shen P, Wei ZQ, Chen YB, Kong HS, Yang Q, et al. Mohnarin report of 2011:
monitoring of bacterial resistance in China. Chin J Nosocomiol 2012; 22(22):4946-4949
3.yang L, Xiao YH, Wang J, Zheng YD, Yan Q, Hou F, et al. Impact of Antimicrobial
resistance on hospitalization costs. China Journal of Pharmaceutical Economics 2009,
1:16-21
4.yin XX, Song FJ, Gong YH, Tu XC, Wang YX Cao SY, et al. A systematic review of
antibiotic utilization in China. J Antimicrob Chemother 2013,68(11):2445-2452
5.jin CM, Xiao AL, Yan L, Chen G. Investigation and analysis on antibacterial drug use in
four cities of China. Chin J Pharmacovigil 2011,8(4):216-219
6.dong LF, Yan H, Wang DL. Antibiotic prescribing patterns in village health clinics
across 10 provinces of Western China. J Antimicrob Chemother 2008, 62:410-415
7.bell BG, Schellevis F, Stobberinggh E, Goossen H, Pringle M. A systematic review and
meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC
Infect Dis 2014, 14:13.
8.ministry of Health of China .The notice on setting-up infectious disease unit in secondlevel
and above general hospital. Ministry of health, 2004. Available from:
http://www.moh.gov.cn/mohbgt/pw10410/200804/27131.shtml. [accessed 10 March
2013]
9.ministry of Health of China, the State Administration of Traditional Chinese Medicine.
Temporary Rules for Pharmaceutical Affairs in Healthcare Institutions. Ministry of
Health, 2002. Available from: http://www.moh.gov.cn/mohyzs/s3577
/200804/18787.shtml. [accessed 10 March 2013]
10. Ministry of Health of China; Rules for Pharmaceutical Affairs in Healthcare
Institutions. Ministry of Health, 2011. Available from:
http://www.moh.gov.cn/mohyzs/s3586/201102/50581.shtml. [accessed 10 March
2013]
11. Ministry of Health of China. The notice on carrying out clinical pharmacist pilot
work. Ministry of Health, 2008. Available from: http://www.moh.gov.cn/mohyzs/
s3577/200804/18775.shtml. [accessed 10 March 2013]
12. Ministry of Health of China. The notice on establishing Ministry of Health committee
of experts on rational drug use. Ministry of Health; 2012. Available
from:http://www.moh.gov.cn/mohyzs/s9980/201206/0cfca0147618458585a6b83fe
194d5ad.shtml. [accessed 10 March 2013]
13. Ministry of Health of China. Administrative regulation for nosocomial infections.
Ministry of Health, 2006. Available from: http://www.moh.gov.cn/mohyzs/s3576/
200804/29294.shtml. [accessed 10 March 2013]
14. Ministry of Health of China. Administrative Regulations for Prescription. Ministry of
Health, 2007. Available from: http://www.moh.gov.cn/mohbgt/pw10704/200804
/18855.shtml. [accessed 10 March 2013]
15. Ministry of Health of China. Administrative Regulations of Clinical Use of Antibiotics.
Ministry of Health, 2012. Available from:
http://www.moh.gov.cn/mohyzs/s3584/201205/54645.shtml. [accessed 10 March
2013]
16. Ministry of Health of China. Principles for the clinical use of antimicrobials. Ministry
of health, 2004. Available from: http://www.moh.gov.cn/mohyzs/s3573/
200804/18544.shtml. [accessed 10 March 2013]
17. Ministry of Health of China. The notice to strengthen antibiotics management.
Ministry of Health, 2009. Available from:
http://www.moh.gov.cn/mohbgt/s9508/200903/39723.shtml. [accessed 10 March
2013]
18. Ministry of Health of China. Guidance in diagnose and therapy of NDM-1 producing
pan-drug resistance Enterobacteriaceae infections (trial version). Ministry of Health.
2010. Available from: . http://www.moh.gov.cn/mohyzs/s8233/201010/49274.shtml.
[accessed 10 March 2013]
19. Ministry of Health of China. National Formulary (2010 edition). Available from:
http://www.moh.gov.cn/mohbgt/s10696/201002/45875.shtml. [accessed 10 March
2013]
20. Ministry of Health of China. National Essential Drugs List (edition for elementary
institutions) (2009). Available from: http://www.moh.gov.cn/mohbgt/s9512/200908/
42506.shtml. [accessed 10 March 2013]
21. Ministry of Health of China. National Essential Drugs List (2012 edition) (2012).
Available from:http://www.moh.gov.cn/wsb/pwsyw/201303/
f01fcc9623284509953620abc2ab189e.shtml. [accessed 10 March 2013]
22. He LX, Xiao YH, Xu YC, Li ZL, Lu Q. National antibiotic treatment guidelines (first
edition). People's Medical Publishing House; Beijing, 2013
23. Xiao YH. Introduction of Mohnarin (Ministry of Health National Antimicrobial
Resistance Investigation Net). Chin J Antibiot 2008; 10:577-578
24. MOH Center for Antibacterial Surveillance. Available from:
http://y.chinadtc.org.cn/program/index.php [Accessed 10 March 2013].
25. Xiao YH. The current status of clinical application of antimicrobial agents in China
and consideration on the rational drug use. Chin Licensed Pharmacist 2011; 4:4-9.
26. Tang SL, Meng QY, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the
challenges to health equity in China. Lancet 2008; 372(9648):1439-1501.
27. Ministry of Health of China. 2011 national special rectification activities program of
clinical use of antibiotics (2011). Available from: http://www.moh.gov.cn/
mohyzs/s3586/201104/51376.shtml. [accessed 10 March 2013]
28. Ministry of Health of China. 2012 national special rectification activities program of
clinical use of antibiotics (2012). Available from:
http://www.moh.gov.cn/mohyzs/s3586/201203/54251.shtml. [accessed 10 March
2013]
29. Ministry of Health of China. Press conference of Ministry of Health in May 8, 2012.
Available from: http://www.moh.gov.cn/mohbgt/s3582/201205/54651.shtml.
[accessed 10 March 2013]
30. Li JY, Chen L, Luo Y, Wang G, Ye HJ. Comparison of antibiotic use before and after
the antibiotic special campaign (Chinese). Herald of Med, 2013,32(6):802-804
31. Xiao SL, Luo LH, Huang YL. Comparative analysis of antibiotics use before and after
its special rectification in our hospital (Chinese). J Luzhou Med College, 2013, 36(1):8486
32. Zheng T, Du DP, Liu D, Xie HJ. Analysis of the inpatients usage of antimicrobial
agents between 2011 and 2012(Chinese). Shanghai Med. 2013,34(4):40-242
33. Pang TY, Luo LW, Pang DM. Efficacy analysis of antibiotic special campaign in our
hospital (Chinese). Pharmaceut Front 2012,10:57-58
34. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li LJ. Changes in Chinese policies to promote
the rational use of antibiotics. PLoS Med, 2013, 10(11): e1001556.
doi:10.1371/journal.pmed.1001556